Literature DB >> 10416911

Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy.

M C Fortin1, S L Amyot, D Geadah, M Leblanc.   

Abstract

OBJECTIVE: To determine to what extent hydrosoluble vitamins are removed by continuous renal replacement therapy (CRRT); to evaluate clearances, removal rates, and evolution of serum concentrations of folic acid and pyridoxal-5'-phosphate (P-5'-P), the active moiety of vitamin B6 during CRRT.
DESIGN: A prospective, non-interventional, descriptive study on vitamin losses induced by CRRT.
SETTING: Medical and surgical intensive care units in a tertiary university-affiliated hospital. PATIENTS: A total of ten critically ill patients in oligoanuric acute renal failure (five treated by continuous venovenous hemofiltration and five by continuous venovenous hemodiafiltration) with a mean effluent rate of 1801 +/- 468 ml/h. Nutritional support was not modified and additional vitamin supplements were not provided during study periods. MEASUREMENTS AND
RESULTS: Concentrations of folic acid and P-5'-P were determined daily during CRRT. Samples for folic acid, P-5'-P, urea, and creatinine were taken simultaneously from the blood at the dialyzer inlet and from the effluent, at CRRT initiation, and daily thereafter over an average of 3.4 +/- 1.2 days. Samples were processed by immunochemiluminescence for folic acid and by radioenzymatic assay for P-5'-P determinations with normal ranges above 6.8 nmol/l and from 11.5 to 179.3 nmol/l, respectively. Marked decreases in serum folic acid and P-5'-P concentrations were noticed over time with mean daily reductions of 12.6 and 13.7%. Serum folic acid concentrations decreased from 42.7 to 16.0 nmol/l and serum P-5'-P decreased from 14.4 to 5.0 nmol/l in the blood coming in to the dialyzer over the study period. Clearances and removal rates were determined from the effluent side. During CRRT, mean (+/- SEM) folic acid and P-5'-P clearances were 20.5 +/- 6.3 ml/min (n = 34) and 13.2 +/- 10.6 ml/min (n = 22), whereas mean urea clearance was 27.1 +/- 5.1 ml/min (n = 26). Folic acid and P-5'-P removal rates were 27.0 +/- 34.2 and 3.4 +/- 2.0 nmol/h, corresponding to mean daily losses of nearly 650 and 80 nmol/day respectively.
CONCLUSION: Significant losses of folic acid and P-5'-P (and most likely of other hydrosoluble vitamins) occur during CRRT. Considering that stores of most hydrosoluble vitamins are relatively low in critically ill patients, supplementation should be provided to patients treated similarly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416911     DOI: 10.1007/s001340050908

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

1.  Dosing Recommendations for Continuous Venovenous Hemodiafiltration with AN69 Filter Membranes and Prismaflex Dialyzers.

Authors:  Eugenia Yeh; Glen Brown
Journal:  Can J Hosp Pharm       Date:  2009-11

2.  Water-Soluble Vitamin Levels and Supplementation in Chronic Online Hemodiafiltration Patients.

Authors:  Nora Schwotzer; Michiko Kanemitsu; Sebastien Kissling; Roger Darioli; Mohammed Benghezal; Serge Rezzi; Michel Burnier; Menno Pruijm
Journal:  Kidney Int Rep       Date:  2020-09-12

3.  [Metabolic management and nutrition in critically ill patients with renal dysfunction : Recommendations from the renal section of the DGIIN, ÖGIAIN, and DIVI].

Authors:  W Druml; M Joannidis; S John; A Jörres; M Schmitz; J Kielstein; D Kindgen-Milles; M Oppert; V Schwenger; C Willam; A Zarbock
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-05-03       Impact factor: 0.840

4.  Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children.

Authors:  Michael Zappitelli; Marisa Juarez; L Castillo; Jorge Coss-Bu; Stuart L Goldstein
Journal:  Intensive Care Med       Date:  2009-01-29       Impact factor: 17.440

5.  Homocysteine and C-reactive protein levels in haemodialysis patients.

Authors:  E Koulouridis; M Tzilianos; A Katsarou; I Costimba; E Klonou; E Panagiotaki; C Georgalidis; A Krokida; N Delaportas; A Lachanas; G Karaliotas; I Kaliolia
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Aderville Cabassi
Journal:  NDT Plus       Date:  2009-02-11

Review 7.  Parenteral nutrition in patients with renal failure - Guidelines on Parenteral Nutrition, Chapter 17.

Authors:  W Druml; H P Kierdorf
Journal:  Ger Med Sci       Date:  2009-11-18

8.  Ischemia-Reperfusion Injury Reduces Kidney Folate Transporter Expression and Plasma Folate Levels.

Authors:  Cheng Yang; Charith U B Wijerathne; Guo-Wei Tu; Connie W H Woo; Yaw L Siow; Susara Madduma Hewage; Kathy K W Au-Yeung; Tongyu Zhu; Karmin O
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.